secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keenova Therapeutics plc (—)
CIK:        0001567892
Form:       8-K
Filed at:   2023-08-29T23:59:59+00:00
Accession:  0001104659-23-096203
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Mallinckrodt receives NYSE American delisting notice after Chapter 11 filing; shares cancelled for no consideration
--------------------------------------------------------------------------------

- NYSE American notified Mallinckrodt on Aug 28, 2023 of immediate trading suspension and delisting proceedings.
- Delisting triggered by Company's voluntary Chapter 11 filing on Aug 28, 2023 in U.S. Bankruptcy Court for Delaware.
- Restructuring Support Agreement (Aug 23, 2023) provides for cancellation of all ordinary shares for no consideration.
- Company's ordinary shares (MNK) will be suspended immediately from NYSE American.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567892/000110465923096203/0001104659-23-096203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567892/000110465923096203/tm2325031d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-096203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer